Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First Patient Dosed in Trial of Sitravatinib in Combination with Tislelizumab

americanpharmaceuticalreviewNovember 13, 2018

Tag: Tislelizumab , combination , sitravatinib

PharmaSources Customer Service